GlassScriptPhysician profile
Jason Andrade
NPI 1245727304
$8,064.76
in general payments reported to CMS, 2019-2025
15 companies · $5,657 in 2025
The $5,657 reported for 2025 was more than what 97% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $734 · 2023: $289 · 2024: $1,385 · 2025: $5,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,059 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,700 · Travel and Lodging: $1,572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,058.69 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,700.00 |
| Travel and Lodging | $1,572.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,060.85 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Pacira Pharmaceuticals Incorporated | $1,179.77 | 2023-2024 | Iovera, Zilretta |
| Boston Scientific Corporation | $237.92 | 2024-2025 | Accolade Sr, Intracept, Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $192.70 | 2025 | Nalu Neurostimulation System |
| Si-Bone, INC. | $147.19 | 2024-2025 | |
| Abbvie INC. | $116.38 | 2023-2024 | Botox |
| Electronic Waveform Lab, INC. | $83.65 | 2025 | |
| Collegium Pharmaceutical, INC. | $77.08 | 2024-2025 | Xtampza |
| Vertex Pharmaceuticals Incorporated | $72.48 | 2024-2025 | |
| Merz Pharmaceuticals, LLC | $68.46 | 2025 | Xeomin |
| Mml US, INC. | $31.14 | 2025 | Reactiv8 |
| International Rehabilitative Sciences, INC | $20.09 | 2025 | Rs-4i Plus With Intersperse |
| Depuy Synthes Sales INC. | $17.59 | 2024 | Orthovisc, Monovisc |
| Bioventus LLC | $15.19 | 2024 | Durolane |
| Spr Therapeutics, INC | $10.35 | 2025 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Andrade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.